Table: Zeria Pharm -2023/24 parent results
May 9 (Reuters)-
Zeria Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2024 Mar 31, 2023 Mar 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 34.02 32.96
(+3.2 pct) (+3.1 pct)
Operating 1.18 1.79
(-34.4 pct) (+129.2 pct)
Recurring 2.69 2.74
(-1.9 pct) (+71.8 pct)
Net 1.64 2.16
(-24.2 pct) (+55.0 pct)
EPS 37.12 yen 48.85 yen
Ann Div 44.00 yen 40.00 yen 46.00 yen
-Q2 Div 22.00 yen 18.00 yen 23.00 yen
-Q4 Div 22.00 yen 22.00 yen 23.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T